Idera Pharmaceuticals Public
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Investors Number:
4
Total Funding:
£5.7M
Technology:
Others
Estimated Revenue:
$1M to $10M
Founded Date:
1989-01-01
Employee Number:
51-100
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Funding Status:
IPO
Last Funding Type:
Seed